Combined oral contraceptives and clinical aspects

Authors

DOI:

https://doi.org/10.33448/rsd-v11i14.36097

Keywords:

Contraceptives; Thromboembolism; Doctor.

Abstract

The use of combined oral contraceptives can increase the incidence of thromboembolism reaching rates that score a risk 2 to 3 times when analyzed on a global scale. The importance of the theme is based on the lack of regular visits to the doctor, which can generate several problems, especially with regard to the use of oral contraceptives. Thus, the present study aimed to discuss combined oral contraceptives and understand the importance of going to the doctor so that he can recommend the best contraceptive, so as not to create a health risk. We sought to understand the impact that the use of combined hormonal contraceptives (CHO) causes in women, that is, the clinical aspects that their use can cause were evaluated. In the methodology, it is a literature review, to which the data collection took place in the search engines Scielo, PubMed, Lilacs and Google Scholars. The time frame of the studies took place between the years 2017 to 2021, in English and Portuguese. Of the studies collected, analyzed and included in this research, 16 remained, which were duly discussed. In the results, it was noticed that the use of combined oral contraceptives can increase the risk of thrombosis in healthy women of reproductive age.

References

Barbosa, T. da S., Coêlho, M. D. G., & Sousa, S. N. (2022). Adverse reactions from prolonged use of oral contraceptives. Research, Society and Development, 11(9), e52111932073. https://doi.org/10.33448/rsd-v11i9.32073

Couto, P. L. S. et al. (2020). Evidências dos efeitos adversos no uso de anticoncepcionais hormonais orais em mulheres. Enferm. Foco, 11(4), 79-86.

Correia, A. M. R.; & Mesquita, A. (2014) Mestrados e Doutoramentos. (2a ed.), Vida Economica Editorial.

Ferreira, L. F.; D´Ávila, A. M. F. C.; & Safatle, G, C, B. (2019). O uso da pílula anticoncepcional e as alterações das principais vias metabólicas. Femina, 47(7), 426-432.

Gialeraki, A. et al. (2018). Oral Contraceptives and HRT Risk of Thrombosis. Clinical and Applied Thrombosis/Hemostasis, 24(2), 217-225.

Gumpel, C. G. (2018). Anticoncepción en la mujer con TEV o con trombofilia sin TEV prévio. Hematologia, 22, 110-116, sep.

Hasegawa, L. E. M., Cavalcante, I. dos S., Ferraz, I. C., Gomes, F. E. S., Carvalho, K. O., Cacau, B. L., Nunes, M. M., Lopes, M. O. A. S., & Dinato, A. O. (2022). The relationship between hormonal contraceptive use and female sexuality: an integrative review. Research, Society and Development, 11(4), e12711423238. https://doi.org/10.33448/rsd-v11i4.23238

Keenan, L. et al. (2018) Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis. The Linacre Quarterly, 85(4), 470-477, 2018.

Lima, Jade Silva e.al. (2017) Risco de trombose associado à terapia dos anticoncepcionais hormonais: uma revisão de literatura. 2017. 76f. Monografia (Bacharelado em Farmácia) – Centro de Ciências da Saúde. Universidade Federal da Paraíba, João Pessoa.

Melo, T A R. (2020) Protocolo clínico para prescrição farmacêutica de contraceptivos hormonais em âmbito institucional. Monografia (Graduação em Farmácia) – Centro de Ciências da Saúde. Universidade Federal da Paraíba, João Pessoa. 272f.

Monteiro, B. I. R.; Santos, M. A. S., & Heinen, R. C. (2018) Associação entre o uso de anticoncepcionais orais e o surgimento de eventos trombóticos. Revista Saúde Física & Mental, 6(1), 41-58.

Morais, L. X.; Santos, L. P.; & Carvalho, I. F. F. R. (2019) Tromboembolismo venoso relacionado ao uso frequente de anticoncepcionais orais combinados. RECHST, 8(1), 91-125.

Oedingen, C.; Scholz, S.; & Razum, O. (2018) Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose. Thrombosis research, v. 165, may, p. 68-78.

Rahhal, A. et al. (2020) Low dose combined oral contraceptives induced thrombotic anterior wall myocardial infarction: a case report. BMC Cardiovasc Disord, 20, 182.

Rocha, L. S. R. A. da, Vieira, M. E. B., & Dominato, A. A. G. . (2021). Cerebral venous thrombosis and the use oral contraceptives: An integrative review . Research, Society and Development, 10(8), e39810817428. https://doi.org/10.33448/rsd-v10i8.17428

Samosir, O.B.; Kiting, A.S; & Aninditya, F. (2020) The Role of Information and Communication Technology and Women Empowerment on Contraceptive Discontinuation in Indonesia. Journal of Preventive Medicine and Public Health, 2020.

Sampaio, A. F. et al. (2019) O uso de contraceptivos orais combinados e o risco de trombose venosa profunda em mulheres em idade reprodutiva. Brazilian Journal of Surgery and Clinical Research – BJSCR, 28(1), 42-48.

Silva, M. A. S. (2018) A importância da Farmácia Clínica nos acompanhamentos de mulheres em uso de anticoncepcionais orais com histórico de eventos trombóticos. Revista Especialize On-line IPOG, ano 9, (16a ed.).

Souza, I. C. A.; & Álvares, A. C. M. (2018) A trombose venosa profunda como reação adversa do uso contínuo de anticoncepcionais orais. Rev. Cient. Sena Aires, 7(1), 54-65.

Tabares, G. G. (2020) Complicaciones provocadas por os anticonceptivos orais combinados. Eventos tromboembólicos. Ginecol Obstet Mex., 88(supl. 1), 140- 155.

Published

20/10/2022

How to Cite

MACHADO, F. G. .; COSTA, J. N. da .; FRANCO, J. V. V. .; LIMA , A. M. de .; REIS , P. C. C. dos; SILVA , S. B. F. da .; SOUZA , M. L. N. de .; ALVES , G. N. .; CONCEIÇÃO , O. de S. da .; GONTIJO, Érica E. L. . Combined oral contraceptives and clinical aspects. Research, Society and Development, [S. l.], v. 11, n. 14, p. e96111436097, 2022. DOI: 10.33448/rsd-v11i14.36097. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/36097. Acesso em: 18 nov. 2024.

Issue

Section

Review Article